Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Breno Toledo Pires de Oliveira | Chief Executive Officer | -- | -- | 1975 |
| Mr. Ramon Sanches Frutuoso Silva | Chief Financial Officer | -- | -- | 1987 |
| Mr. Carlos Roberto Scorsi | Chief Operating officer | -- | -- | 1962 |
| Mr. Adalmario Ghovatto Satheler do Couto C.F.A. | Investor Relations Officer | -- | -- | 1981 |
| Joao Felipe Khamis Aguilar | Risks & Compliance Officer | -- | -- | -- |
| Mr. Luiz Eduardo Sales Clavis | Vice President of Commercial & Marketing | -- | -- | 1971 |
| Mauricio Christovam | Senior Human Resources Officer | -- | -- | -- |
| Mr. Hélio Segouras | Head of Consumer Health | -- | -- | -- |
Hypera S.A.
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, pleased, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, Luna, moon, Lydian, macrodantin, MaxSulid, Milgamma, Mioflex A, Nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, Softalm, Tacroz, Tinodin, Umma, and velunid brands. The company also provides sun protection and moisturizing skin care products under the Mantecorp Skincare brands; similar products under the Doralgina, Dropy D, Equilibrisse, balance, Flavonid, Histamin, neofresh, neolefrin, neoquimica Vitamins, Neosorum, and Torsilax brands; and over-the-counter drugs under the Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina brands, as well as similar and generic drugs under the Neo Química brand. In addition, it offers nutritional and vitamin supplement products under the Tamarine, Biotônico Fontoura, and Zero-Cal brands; and generic medicines under the Hydroxyzine, Sodium Diclofenac, Dipyron, Ibuprofen, Losartan Potassium, Mal Dexchlorpheniramine, Naproxene, Paracetamol, Simethicon, Loratadine, Omeprazole, Tadalaphyl, and Desogestrel brands. The company was formerly known as Hypermarcas S.A. and changed its name to Hypera S.A. in February 2018. Hypera S.A. was founded in 1999 and is headquartered in São Paulo, Brazil.
Corporate Governance
Upcoming Events
April 23, 2025 at 7:00 PM UTC
Hypera S.A. Earnings Date
Recent Events
April 4, 2025 at 12:00 AM UTC
Ex-Dividend Date